Date published: 2025-11-22

1-800-457-3801

SCBT Portrait Logo
Seach Input

POU2F3 Inhibitors

POU2F3 Inhibitors encompasses a range of compounds that indirectly modulate the activity of POU2F3, a transcription factor involved in various cellular functions. This class is distinct in that it does not contain chemicals that bind directly to POU2F3, but rather includes molecules that influence the protein's activity through indirect pathways. The diversity of these inhibitors reflects the multifaceted nature of POU2F3's role in cellular processes and the complex networks in which it operates. Key members of this class include inhibitors of signaling pathways like PI3K/AKT, MAPK, and mTOR, as well as modulators of epigenetic mechanisms and other cellular signaling pathways. PI3K/AKT pathway inhibitors, such as Wortmannin and LY294002, exemplify this category by targeting a pathway that intersects with POU2F3's regulatory functions. These compounds act by disrupting the signaling cascade, thereby potentially influencing POU2F3's activity. Similarly, inhibitors targeting the MAPK pathway, like PD98059 and U0126, operate by altering the kinase activity within this signaling network, which can indirectly impact the transcriptional control exerted by POU2F3. Epigenetic modulators in this class, including Trichostatin A (a histone deacetylase inhibitor) and 5-Azacytidine (a DNA methyltransferase inhibitor), underscore the indirect approach of these inhibitors. By modifying the epigenetic landscape, they can affect gene expression patterns relevant to POU2F3's function.

This class includes compounds like Rapamycin, an mTOR inhibitor, reflecting the nuanced interplay between various signaling pathways and transcriptional regulation. The inclusion of histone methylation and p53 pathway modulators, such as BIX-01294 and Nutlin-3, extends the scope of POU2F3 Inhibitors to broader cellular mechanisms like chromatin dynamics and stress response. Cyclopamine, targeting the Hedgehog signaling pathway, illustrates the wide-ranging mechanisms through which these inhibitors can potentially influence POU2F3 activity. The chemical diversity within the POU2F3 Inhibitors class is a testament to the complex biological networks and interactions that govern cellular function. Each inhibitor, by acting on a different component of these networks, contributes to the indirect modulation of POU2F3, highlighting the intricate balance of cellular signaling and transcriptional regulation.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

An inhibitor of phosphoinositide 3-kinases (PI3K), potentially reducing POU2F3 activity by altering downstream signaling pathways.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A selective inhibitor of PI3K, which may indirectly affect POU2F3 through altered PI3K/AKT signaling.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

A histone deacetylase inhibitor, potentially modulating chromatin structure and affecting POU2F3-mediated transcription.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

A DNA methyltransferase inhibitor, possibly influencing POU2F3 expression by altering DNA methylation patterns.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

An inhibitor of MEK, a kinase in the MAPK pathway, possibly impacting POU2F3 activity through altered signaling.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

A JNK inhibitor, potentially affecting POU2F3 function by modulating stress response pathways.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

An inhibitor of p38 MAPK, which might influence POU2F3 activity through stress-related signaling pathways.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

An mTOR inhibitor, which may indirectly affect POU2F3 activity through the PI3K/AKT/mTOR pathway.

Histone Lysine Methyltransferase Inhibitor Inhibitor

935693-62-2 free basesc-202651
5 mg
$148.00
4
(1)

An inhibitor of G9a histone methyltransferase, potentially affecting POU2F3-mediated transcriptional regulation.

Nutlin-3

548472-68-0sc-45061
sc-45061A
sc-45061B
1 mg
5 mg
25 mg
$56.00
$212.00
$764.00
24
(1)

A MDM2 antagonist, potentially influencing POU2F3 by modulating p53 pathways.